Did Bill Clinton repeal Glass Steagall?
Yes, the Bill & Melinda Gates Foundation (BMGF) entered into an agreement to purchase BioNTech shares in August 2019. The foundation agreed to purchase 3,038,674 ordinary shares of BioNTech for approximately $55 million. The investment was tied to agreements requiring BioNTech to conduct research and development activities focused on treatments and vaccines for HIV and tuberculosis. Under the terms of this deal, if BioNTech failed to meet certain R&D conditions, the foundation retained the right to sell the shares back to the company at the initial purchase price or fair market value, whichever was higher, demonstrating a targeted philanthropic and investment approach to medical innovation.